Adlai Nortye ANL
NASDAQ ANL
$15.76 -0.24 (-1.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Other Non-Current Assets (2022 - 2026)

Updated

Adlai Nortye (ANL) reported Other Non-Current Assets of $80,000 for Q2 2026, down 99.6% from $18.24 million a year earlier.

Analysis

Adlai Nortye (ANL) Other Non-Current Assets (2022 - 2026) Analysis & Trends

At the end of FY2025, Adlai Nortye posted Other Non-Current Assets of $15.73 million.

  • Other Non-Current Assets has a three-year compound annual growth rate of -57.8% (FY2022 to FY2025).
  • By year, Other Non-Current Assets came in at $252.81 million in FY2023 (+20.4%) and $210.04 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Adlai Nortye 549.39 Mn 450.09 Mn - 80,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 80,000.00
Dec 31, 2025 15.73 Mn
Jun 30, 2025 18.24 Mn
Dec 31, 2023 252.81 Mn
Dec 31, 2022 210.04 Mn
API Access

Adlai Nortye Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ANL&period=max&api_key=YOUR_API_KEY